TrialPloS one2013

Phospholipid metabolites in recurrent glioblastoma: in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy.

Elke Hattingen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.